Inverse agonism by Dmt-Tic analogues and HS 378, a naltrindole analogue

European Journal of Pharmacology

Volumn 406, Issue 1, 2000, Pages

  Labarre, Maryse ^a   Butterworth, Joanne ^a   St Onge, Stephane ^a   Payza, Kemal ^a   Schmidhammer, Helmut ^b   Salvadori, Severo ^c   Balboni, Gianfranco ^d   Guerrini, Remo ^c   Bryant, Sharon D ^e   Lazarus, Lawrence H ^e  

^a ASTRAZENECA   (United Kingdom)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c UNIVERSITY OF FERRARA   (Italy)

^d UNIVERSITY OF CAGLIARI   (Italy)

^e NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Antagonism; Dmt Tic; Inverse agonism

Indexed keywords

DELTA OPIATE RECEPTOR AGONIST; HS 378; NALTRINDOLE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; NONHUMAN; PHARMACOPHORE; PRIORITY JOURNAL;

BENZAMIDES; BENZENEACETAMIDES; BINDING, COMPETITIVE; CELL LINE; CELL MEMBRANE; DIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; ISOQUINOLINES; NALTREXONE; NARCOTIC ANTAGONISTS; PIPERAZINES; PYRROLIDINES; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; SULFUR RADIOISOTOPES; TETRAHYDROISOQUINOLINES;

EID: 0034613309     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00636-1     Document Type: Article

References (8)

1. Bryant S.D., Balboni G., Guerrini R., Salvadori S., Tomatis R., Lazarus L.H. Opioid diketopiperazines: refinement of the δ opioid antagonist pharmacophore. Biol. Chem. 378:1997;107-114.
2. Bryant S.D., Salvadori S., Cooper P.S., Lazarus L.H. New δ opioid antagonists as pharmacological probes. Trends Pharmacol. Sci. 19:1998;42-46.
3. Lazarus L.H., Bryant S.D., Cooper P.S., Guerrini R., Balboni G., Salvadori S. Design of δ-opioid peptide antagonists for emerging drug applications. Drug Dev. Today. 3:1998;284-294.
4. Salvadori S., Attila M., Balboni G., Bianchi C., Bryant S.D., Crescenzi O., Guerrini R., Picone D., Tancredi T., Temussi P.A., Lazarus L.H. δ Opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides. Mol. Med. 1:1995;678-689.
5. Salvadori S., Guerrini R., Balboni G., Bianchi C., Bryant S.D., Cooper P.S., Lazarus L.H. Further studies on the Dmt-Tic pharmacophore: hydrophobic substituents at the C-terminus endows δ antagonists to manifest μ agonism or μ antagonism. J. Med. Chem. 42:1999;5010-5019.
6. Sasaki Y., Suto T., Ambo A., Ouchi H., Yamamoto Y. Biological properties of opioid peptides replacing Tyr at position 1 by 2,6-dimethyl-Tyr. Chem. Pharm. Bull. 47:1999;1506-1507.
7. Schmidhammer H., Krassnig R., Greiner E., Schultz J., White A., Berzetei-Gurske I.P. Synthesis and biological evaluation of 14-alkoxymorphinans: Part 15. Novel delta opioid receptor antagonists with high affinity and selectivity in the 14-alkoxy-substituted indolomorphinan series. Helv. Chim. Acta. 81:1998;1064-1069.
8. Valiquette M., Vu H.K., Yue S.Y., Wahlestedt C., Walker P. Involvement of Trp-284, Val-296, and Val-297 of the human δ-opioid receptor in binding of δ-selective ligands. J. Biol. Chem. 271:1996;18789-18796.